RNPEP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.971400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.291000E-01
Normal-vs-Stage2
6.928000E-01
Normal-vs-Stage3
9.068400E-01
Normal-vs-Stage4
5.593000E-01
Stage1-vs-Stage2
4.816800E-01
Stage1-vs-Stage3
9.657800E-01
Stage1-vs-Stage4
5.084000E-01
Stage2-vs-Stage3
5.185400E-01
Stage2-vs-Stage4
6.612600E-01
Stage3-vs-Stage4
5.546800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.953400E-01
Normal-vs-AfricanAmerican
3.800400E-01
Normal-vs-Asian
3.534800E-01
Caucasian-vs-AfricanAmerican
5.714400E-02
Caucasian-vs-Asian
2.828200E-02
AfricanAmerican-vs-Asian
8.836400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.753200E-01
Normal-vs-Female
8.265600E-01
Male-vs-Female
8.879000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.220000E-01
Normal-vs-Age(41-60Yrs)
7.109600E-01
Normal-vs-Age(61-80Yrs)
8.736000E-01
Normal-vs-Age(81-100Yrs)
3.924400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.352600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.814600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.032200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.954200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.890590E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.333600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.868200E-01
Normal-vs-Daily Drinker
8.168400E-01
Normal-vs-Weekly Drinker
6.272400E-01
Normal-vs-Occasional Drinker
4.314400E-01
Normal-vs-Social Drinker
8.394400E-01
Non Drinker-vs-Daily Drinker
7.561200E-01
Non Drinker-vs-Weekly Drinker
5.173800E-01
Non Drinker-vs-Occasional Drinker
2.200000E-01
Non Drinker-vs-Social Drinker
9.394800E-01
Daily Drinker-vs-Weekly Drinker
7.964400E-01
Daily Drinker-vs-Occasional Drinker
4.921800E-01
Daily Drinker-vs-Social Drinker
8.420400E-01
Weekly Drinker-vs-Occasional Drinker
6.603000E-01
Weekly Drinker-vs-Social Drinker
5.897000E-01
Occasional Drinker-vs-Social Drinker
2.895000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.539200E-01
Normal-vs-Grade 2
4.722100E-02
Normal-vs-Grade 3
2.419700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.620000E-02
Grade 1-vs-Grade 3
4.380000E-02
Grade 1-vs-Grade 4
3.539200E-01
Grade 2-vs-Grade 3
5.939800E-01
Grade 2-vs-Grade 4
4.722100E-02
Grade 3-vs-Grade 4
2.419700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.500400E-01
Normal-vs-NonDiabetic
6.844000E-01
Diabetic-vs-NonDiabetic
1.420450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.943000E-01
Normal-vs-NoPancreatitis
7.977600E-01
Pancreatitis-vs-NoPancreatitis
2.546400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.669200E-01
Normal-vs-N1
8.033000E-01
N0-vs-N1
4.904600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.274200E-01
Normal-vs-TP53-NonMutant
9.442200E-01
TP53-Mutant-vs-TP53-NonMutant
1.860040E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
